Vergoeding 2018-2022 voor ATC-subgroep J05AX : Overige antivirale middelen
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| J05AX09 Maraviroc (Celsentri ®) | 766.600 | 742.590 | 710.150 | 615.040 | 569.020 |
| J05AX18 Letermovir (Prevymis ®) | . | 380.120 | 1.051.700 | 1.833.000 | 2.675.900 |
| J05AX29 Fostemsavir (Rukobia ®) | . | . | . | . | 35.340 |
| J05AX Overige antivirale middelen | . | . | . | . | 116.260 |
| Totaal | 766.600 | 1.122.710 | 1.761.850 | 2.448.040 | 3.396.520 |